Vascular dementia

被引：22

作者：

Schneck, Michael J. ^{[1
]}

机构：

[1] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL 60153 USA

来源：

TOPICS IN STROKE REHABILITATION | 2008年 / 15卷 / 01期

关键词：

anticholinesterase inhibitors; memantine; vascular dementia;

D O I：

10.1310/tsr1501-22

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Vascular dementia (VaD) is the second most common form of dementia after Alzheimer's dementia (AD). It is characterized by loss of executive function with milder memory loss as compared with AD and is associated with cerebral brain infarction or hemorrhage. Treatment is predominantly focused on cardiovascular risk factor reduction, but anticholinesterase inhibitors and memantine may play a role. The data is most robust for donepezil.

引用

页码：22 / 26

页数：5

共 31 条

[1]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

[2]

[Anonymous], 2000, COCHRANE DATABASE SY

[3] Galantamine treatment of vascular dementia: A randomized trial [J].

Auchus, A. P. ;

Brashear, H. R. ;

Salloway, S. ;

Korczyn, A. D. ;

De Deyn, P. P. ;

Gassmann-Mayer, C. .

NEUROLOGY, 2007, 69 (05) :448-458

[4] Statins and cognitive function in the elderly - The Cardiovascular Health Study [J].

Bernick, C ;

Katz, R ;

Smith, NL ;

Rapp, S ;

Bhadelia, R ;

Carlson, M ;

Kuller, L .

NEUROLOGY, 2005, 65 (09) :1388-1394

[5] Efficacy and tolerability of donepezil in vascular dementia -: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial [J].

Black, S ;

Román, GC ;

Geldmacher, DS ;

Salloway, S ;

Hecker, J ;

Burns, A ;

Perdomo, C ;

Kumar, D ;

Pratt, R .

STROKE, 2003, 34 (10) :2323-2330

[6] Vascular dementia - Stroke risk and sequelae define therapeutic approaches [J].

Black, SE .

POSTGRADUATE MEDICINE, 2005, 117 (01) :15-+

[7] Rivastigmine for vascular cognitive impairment [J].

Craig, D ;

Birks, J .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02)

[8] Galantamine for vascular cognitive impairment [J].

Craig, D ;

Birks, J .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01)

[9] Use of antidementia agents in vascular dementia: Beyond Alzheimer disease [J].

Farlow, Martin R. .

MAYO CLINIC PROCEEDINGS, 2006, 81 (10) :1350-1358

[10] Predictors of survival in African American patients with AD, VaD, or stroke without dementia [J].

Freels, S ;

Nyenhuis, DL ;

Gorelick, PB .

NEUROLOGY, 2002, 59 (08) :1146-1153

← 1 2 3 4 →